Literature DB >> 17080297

Introduction of G1 phase arrest in Human Hepatocellular carcinoma cells (HHCC) by APMCF1 gene transfection through the down-regulation of TIMP3 and up-regulation of the CDK inhibitors p21.

Qinlong Li1, Wei Yan, Shengquan Cheng, Shuangping Guo, Wenyong Wang, Zhipei Zhang, Li Wang, Jing Zhang, Wenliang Wang.   

Abstract

We previously found that there was up-regulation of APMCF1 expression in apoptotic MCF-7 cells. Moreover, bioinformatics analysis has found that APMCF1 molecules had similar size and structure with molecules which belong to small G-protein superfamily. We presume that APMCF1 plays certain biological role in the regulation of cell proliferation and apoptosis. In this study, we first detected the expression pattern of APMCF1 in human hepatocellular carcinoma cell line and find no expression in Human Hepatocellular carcinoma cells (HHCC) and enhanced expression in HepG2 cells. Expression of liposome-mediated ectogenic APMCF1 induced inhibition of HHCC growth and cell cycle, and RNAi inhibited APMCF1 expression and promoted HepG2 cell growth. Results of cell cycle gene chips analysis showed up-regulation of p21 expression and down-regulation of TIMP3 in HHCC cells expressing ectogenic APMCF1, indicating that APMCF1 participates at least partially in cell cycle regulation through regulating genes such as p21 and TIMP3.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080297     DOI: 10.1007/s11033-006-9007-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  33 in total

Review 1.  The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis.

Authors:  C Chang; Z Werb
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

2.  Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced.

Authors:  Hideki Kamitani; Seijiro Taniura; Kenji Watanabe; Makoto Sakamoto; Takashi Watanabe; Thomas Eling
Journal:  Neuro Oncol       Date:  2002-04       Impact factor: 12.300

3.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model.

Authors:  William W Spurbeck; Catherine Y C Ng; Ted S Strom; Elio F Vanin; Andrew M Davidoff
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

5.  RB activation defect in tumor cell lines.

Authors:  Cristina Broceño; Scott Wilkie; Sibylle Mittnacht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-11       Impact factor: 11.205

6.  Effect of p53 status on tumor response to antiangiogenic therapy.

Authors:  Joanne L Yu; Janusz W Rak; Brenda L Coomber; Daniel J Hicklin; Robert S Kerbel
Journal:  Science       Date:  2002-02-22       Impact factor: 47.728

7.  Bcl-2 expression and frequency of apoptosis correlate with morphogenesis of colorectal neoplasia.

Authors:  Y Suzuki; T Honma; S Hayashi; Y Ajioka; H Asakura
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

8.  Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.

Authors:  Alexander Yu Nikitin; Chia-Yang Liu; Andrea Flesken-Nikitin; Chi-Fen Chen; Phang-Lang Chen; Wen-Hwa Lee
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

9.  Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio.

Authors:  Delphine Javelaud; Francoise Besancon
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

10.  The ribosome regulates the GTPase of the beta-subunit of the signal recognition particle receptor.

Authors:  G Bacher; M Pool; B Dobberstein
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

View more
  7 in total

1.  Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.

Authors:  Fan Lin; Yuyuan Li; Jie Cao; Shaofeng Fan; Jifeng Wen; Guanghui Zhu; Hong Du; Yanxiao Liang
Journal:  Mol Biol Rep       Date:  2010-12-29       Impact factor: 2.316

2.  Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis.

Authors:  Zhi Song; Ren Li; Nan You; Kaishan Tao; Kefeng Dou
Journal:  Mol Biol Rep       Date:  2010-03-19       Impact factor: 2.316

3.  Novel ultrasound-targeted microbubble destruction mediated short hairpin RNA plasmid transfection targeting survivin inhibits gene expression and induces apoptosis of HeLa cells.

Authors:  Zhiyi Chen; Kun Liang; Mingxing Xie; Xinfang Wang; Qing Lü; Jing Zhang
Journal:  Mol Biol Rep       Date:  2008-11-09       Impact factor: 2.316

4.  Subcellular localization of APMCF1 and its biological significance of expression pattern in normal and malignant human tissues.

Authors:  Yaqing Zhang; Qinlong Li; Feng Zhu; Jihong Cui; Kainan Li; Qing Li; Ruian Wang; Wenyong Wang; Weihua Wang; Wei Yan
Journal:  J Exp Clin Cancer Res       Date:  2009-08-09

5.  Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis.

Authors:  Peng Liu; Jinhong Wei; Feiyu Mao; Zechang Xin; Heng Duan; Yan Du; Xiaodong Wang; Zhennan Li; Jianjun Qian; Jie Yao
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

6.  SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis.

Authors:  Qiang Ma; Xiuxiu Wu; Jing Wu; Zhiyong Liang; Tonghua Liu
Journal:  Int J Oncol       Date:  2017-08-31       Impact factor: 5.650

7.  Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine.

Authors:  Yan Guo; Xi'an Li; Xiang Sun; Jiancai Wang; Xu Yang; Xin Zhou; Xinping Liu; Wenchao Liu; Jianlin Yuan; Libo Yao; Xia Li; Lan Shen
Journal:  Int J Biol Sci       Date:  2019-07-03       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.